Kidney cancer, Renal cell cancer
Results
Phase 3
This trial looked at a drug called pazopanib after surgery to remove kidney cancer. It was for people who had the most common type of kidney cancer called renal cell cancer.
Recruitment start: 1 December 2010
Recruitment end: 19 June 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Hawkins
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
Novartis
Last reviewed: 19 Dec 2017
CRUK internal database number: 10684
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
